(Q28216633)

English

Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer

scientific article (publication date: June 2002)

Statements

Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer (English)
0 references
Kazuya Kudoh
0 references
Yoshihito Ichikawa
0 references
Sadao Yoshida
0 references
Misako Hirai
0 references
Yoshihiro Kikuchi
0 references
Ichiro Nagata
0 references
Masanao Miwa
0 references
Kazuhiko Uchida
0 references
1 June 2002
0 references
99
0 references
4
0 references
579-82
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit